Hypersensitivity and cross-reactivity to cisplatin and carboplatin
Cisplatin was the first of the platinum drugs. Second-generation platinum derivative was carboplatin that its efficacy in the treatment of many malignancies is equal to cisplatin, and its toxicity profile is more favorable. Here we report on a 50-year-old woman with a history of cervix cancer who...
Main Authors: | Gholamreza Faridaalaee, Amin Mahboubi, Seyed Hesam Rahmani |
---|---|
Format: | Article |
Language: | English |
Published: |
Kerman University of Medical Sciences
2016-07-01
|
Series: | Journal of Emergency Practice and Trauma |
Subjects: | |
Online Access: | http://www.jept.ir/article_15487_cc7e8503f00163755fb27175dcbd54dd.pdf |
Similar Items
-
Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin
by: Shinichi Tate, et al.
Published: (2021-02-01) -
The influence of acute kidney disease on the clinical outcomes of patients who received cisplatin, carboplatin, and oxaliplatin
by: Alexandre Ricardo Da Silva Fernandes, et al.
Published: (2022-01-01) -
Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01) -
Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01) -
A Potentially Less Nephrotoxicity of Carboplatin Over Cisplatin as Radiosensitizer in Head-neck Cancer
by: Mahfujul Ahmed Riad
Published: (2022-08-01)